Trends in engagement in the cascade of care for opioid use disorder, Vancouver, Canada, 2006-2016
- PMID: 29894910
- PMCID: PMC6062451
- DOI: 10.1016/j.drugalcdep.2018.04.026
Trends in engagement in the cascade of care for opioid use disorder, Vancouver, Canada, 2006-2016
Abstract
Background: A cascade of care framework has been proposed to identify and address implementation gaps in addiction medicine. Using this framework, we characterized temporal trends in engagement in care for opioid use disorder (OUD) in Vancouver, Canada.
Methods: Using data from two cohorts of people who use drugs, we assessed the yearly proportion of daily opioid users achieving four sequential stages of the OUD cascade of care [linkage to addiction care; linkage to opioid agonist treatment (OAT); retention in OAT; and stability] between 2006 and 2016. We evaluated temporal trends of cascade indicators, adjusting for socio-demographic characteristics, HIV/HCV status, substance use patterns, and social-structural exposures.
Results: We included 1615 daily opioid users. Between 2006 and 2016, we observed improvements in linkage to care (from 73.2% to 78.9%, p = <0.001), linkage to (from 69.2% to 70.6%, p = 0.011) and retention in OAT (from 29.1% to 35.5%, p = <0.001), and stability (from 10.4% to 17.1%, p = <0.001). In adjusted analyses, later calendar year of observation was associated with increased odds of linkage to care (Adjusted Odds Ratio [AOR] = 1.02, 95% Confidence Interval [CI]: 1.01-1.04), retention in OAT (AOR 1.02, 95% CI: 1.01-1.04) and stability (AOR = 1.03, 95% CI: 1.01-1.05), but not with linkage to OAT (AOR 1.00, 95% CI: 0.98-1.01).
Conclusions: Temporal improvements in OUD cascade of care indicators were observed. However, only a third of participants were retained in OAT in 2016. These findings suggest the need for novel approaches to improve engagement in care for OUD to address the escalating opioid-related overdose crisis.
Keywords: Addiction; Buprenorphine/naloxone; Cascade of care; Methadone; Opioid agonist therapy; Opioid use disorder; Performance metrics; Quality indicators.
Copyright © 2018 Elsevier B.V. All rights reserved.
Conflict of interest statement
The University of British Columbia has received unstructured funding from NG Biomed, Ltd., an applicant to the Canadian federal government for a licence to produce medical cannabis, to support M-JM. JM has received limited unrestricted funding, paid to his institution, from Abbvie, Bristol-Myers Squibb, Gilead Sciences, Janssen, Merck and ViiV Healthcare. All other authors declare no competing interests.
Figures
References
-
- Ali MK, Bullard KM, Gregg EW, Del Rio C. A cascade of care for diabetes in the United States: Visualizing the gaps. Ann Intern Med. 2014;161:681–689. - PubMed
-
- Ali-Faisal SF, Colella TJ, Medina-Jaudes N, Benz Scott L. The effectiveness of patient navigation to improve healthcare utilization outcomes: A meta-analysis of randomized controlled trials. Patient Educ Couns. 2017;100:436–448. - PubMed
-
- BC Coroners Service. Illicit Drug Overdose Deaths in BC (Jan 2008 – Feb 2018) 2018.
-
- Byers T. Assessing the value of patient navigation for completing cancer screening. Cancer Epidemiol Biomarkers Prev. 2012;21:1618–1619. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
